ACCEL-DAPAGLIFLOZIN
ACCEL-DAPAGLIFLOZIN
Approved
DIN Number
02543184
Drug Class
Human
Market Date
N/A
Company
HC
accel pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02543184
AIG Number0156370001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BK01 DAPAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.18
Health Canada Classification
ACTIVE INGREDIENTS (1)
DAPAGLIFLOZINActive
Strength: 5 MG
Monograph: DAPAGLIFLOZIN